Journals / Clinical and Experimental Health Sciences / 2013 / Cilt: 3 - Sayı: 5

A review on agmatine as a novel neurotransmitter/neuromodulator

Yeni bir nörotransmitter/nöromodülatör olarak agmatine genel bir bakış

Pages
1–1
Publication Date
2014-01-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, agmatine can be a new candidate of novel therapeutic targets by further revealing the underlying molecular mechanisms in related physiological and pathological conditions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Agmatine, an endogenous amine, which is formed by decarboxylation of L-arginine, a semi essential amino acid, by arginine decarboxylase (ADC) and degraded by agmatinase can be defined as a putative neurotransmitter/neuromodulator.
📊
Key Findings & Data:Agmatine binds to alpha-adrenergic and imidazoline receptors, blocks nicotinic cholinergic, serotoninergic 5-HT3 and glutamatergic N-methyl-D-aspartate (NMDA) receptors and inhibits nitric oxide synthase (NOS).
💡
Conclusion & Impact:Thus, agmatine can be a new candidate of novel therapeutic targets by further revealing the underlying molecular mechanisms in related physiological and pathological conditions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Agmatin · imidazolin reseptörleri · alfa-adrenerjik reseptörler

Abstract

Agmatine, an endogenous amine, which is formed by decarboxylation of L-arginine, a semi essential amino acid, by arginine decarboxylase (ADC) and degraded by agmatinase can be defined as a putative neurotransmitter/neuromodulator. Agmatine is widely distributed in the body except from brain. Agmatine binds to alpha-adrenergic and imidazoline receptors, blocks nicotinic cholinergic, serotoninergic 5-HT3 and glutamatergic N-methyl-D-aspartate (NMDA) receptors and inhibits nitric oxide synthase (NOS). Agmatine, an endogenous substance, modulating several functions in nervous system, is shown to have a wide range of pharmacological effects such as antinociceptive, antiinflammatory, preventing abstinence syndromes of morphine dependence, anxiolytic/antidepressant, neuroprotective, anticonvulsant and recently cognitive enhancing effects. Thus, agmatine can be a new candidate of novel therapeutic targets by further revealing the underlying molecular mechanisms in related physiological and pathological conditions.

Özet

Yarı esansiyel bir aminoasit olan L-arjininin arjinin dekarboksilaz (ADC) aracılığıyla dekarboksillenmesiyle oluşan ve agmatinazla yıkıma uğrayan endojen bir amin olan agmatin yeni bir nörotransmitter/nöromodulatör olarak tanımlanabilir. Agmatin beyin dışında vücutta yaygın dağılım gösterir. Agmatin alfa-adrenerjik ve imidazolin reseptörlerine bağlanır, nikotinik kolinerjik, serotonerjik 5-HT3 ve glutamaterjik N-metil-D-aspartat (NMDA) reseptörlerini bloke eder ve nitrik oksit sentazı (NOS) bloke eder. Endojen bir madde olan ve sinir sisteminde birçok fonksiyonu modüle ettiği bilinen agmatin çok geniş bir farmakolojik etki spektrumuna sahiptir. Bu etkiler arasında; antinosiseptif, antiinflamatuvar, morfin yoksunluğu semptomlarını baskılayıcı, antidepresan, nöroprotektif, antikonvülsan ve son olarak bilişsel fonksiyonları artırıcı etkisi bulunmaktadır. Agmatin, ilgili fizyolojik ve patolojik olaylardaki etkisinin altında yatan moleküler mekanizmaların daha iyi aydınlatılması ile yeni tedavi hedefleri için bir aday olabilir.

🔖

Cite This Article

GÜMRÜ, S., ŞAHİN, C., ARICIOĞLU, F. (2014). A review on agmatine as a novel neurotransmitter/neuromodulator. Clinical and Experimental Health Sciences, Cilt: 3 - Sayı: 5, 1–1. https://ajindex.com/articles/719666

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Oteka K, Ruggiero DA, Regunathan S, Wang H, Milner TA, Reis DJ. Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res. 1998;787:1-14.
  2. Morgan NG, Chan SL, Mourtada M, Monks LK, Ramsden CA. Imidazolines and pancreatic hormone secretion. Ann NY Acad Sci. 1999;881:217-228.
  3. Olmos G, Degregorio-Rocasolano N, Regalado MP, Gasull T, Boronat MA, Trullas R, Villarroel A, Lerma J, Garcia JA, Wang G, Gorbatyuk O, Dayanithi G, Ouyang W, Wang J, Milner TA, Regunathan S, Reis DJ. Evidence for endogenous agmatine in hypothalamoneurohypophysial tract and its modulation on vasopressin release and Ca 2+ channels. Brain Res. 2002;932:25-36.
  4. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 1994;263(5149):966-969.
  5. Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha-adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther. 1984;230:232-236.
  6. Ernsberger P, Graves ME, Graff LM. I1-imidazoline receptors: Definition, characterization, distribution and transmembrane signaling. Ann NY Acad Sci. 1995;763:22-42.
  7. Raasch W, Schafer U, Chun J, Dominiak P. Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol. 2001;133:755-780.
  8. Walter R, Regunathan S, Li G, Reis DJ. Agmatine is widely and unequally distributed in rat organs. Ann NY Acad Sci. 1995;763:330-334.
  9. Molderings GJ, Heinen A, Menzel S, Lübbecke F, Homann J, Göthert M. Gastrointestinal uptake of agmatine. Ann Ny Acad Sci. 2003;1009: 44Li G, Regunathan S, Reis DJ. Agmatine is synthesized by a mitochondrial arginine decarboxylase in rat brain. Ann NY Acad Sci. 1995;763:325-329.
  10. Regunathan S, Feinstein DL, Raasch W, Reis DJ. Agmatine, decarboxylated arginine is localized and synthesized in glial cells. Neuroreport. 1995;6:1987-1900.
  11. Sastre M, Regunathan S, Reis DJ. Uptake of agmatine into rat brain synaptosomes: Possible role of ca-tion channels. J Neurochem. 1997;69:2421-2426.
  12. Reis DJ, Yang XC, Milner TA. Agmatine containing axon terminals in rat hippocampus from synapses on pyramidal cells. Neurosci Lett. 1998;250:185-188.
  13. Reis DJ, Regunathan S. Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci. 2000;21:187-193.
  14. Reis DJ, Regunathan S. Agmatine: An endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain. J Auton Nerv Syst. 1998;72:80-85.
  15. Yang X, Reis DJ. Agmati